Jacobs Levy Equity Management
AGTC

Jacobs Levy Equity Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Jacobs Levy Equity Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-348,560
Closed -$1.05M – 1120
2021
Q3 		$1.05M Sell
348,560
-108,265
-24% -$386K 0.01% 741
2021
Q2 		$1.79M Sell
456,825
-12,799
-3% -$53.1K 0.01% 624
2021
Q1 		$2.38M Buy
469,624
+379,716
+422% +$1.97M 0.02% 564
2020
Q4 		$368K Buy
89,908
+18,047
+25% +$88.6K ﹤0.01% 891
2020
Q3 		$349K Sell
71,861
-38,452
-35% -$210K ﹤0.01% 869
2020
Q2 		$611K Sell
110,313
-41,698
-27% -$191K 0.01% 756
2020
Q1 		$499K Buy
152,011
+48,445
+47% +$255K 0.01% 754
2019
Q4 		$468K Buy
103,566
+20,942
+25% +$66.2K ﹤0.01% 790
2019
Q3 		$344K Buy
82,624
+1,000
+1% +$3.61K ﹤0.01% 767
2019
Q2 		$309K Buy
81,624
+18,265
+29% +$74.9K ﹤0.01% 808
2019
Q1 		$265K Hold
63,359
– – ﹤0.01% 855
2018
Q4 		$158K Sell
63,359
-14,000
-18% -$82K ﹤0.01% 912
2018
Q3 		$565K Buy
77,359
+7,500
+11% +$32.8K 0.01% 752
2018
Q2 		$258K Buy
+69,859
New +$323K ﹤0.01% 916
2018
Q1 		– Sell
-14,000
Closed -$50K – 1090
2017
Q4 		$50K Buy
+14,000
New +$52.9K ﹤0.01% 967
2017
Q3 		– Sell
-20,900
Closed -$107K – 1033
2017
Q2 		$107K Sell
20,900
-5,900
-22% -$33.1K ﹤0.01% 892
2017
Q1 		$185K Buy
26,800
+400
+2% +$3.13K ﹤0.01% 808
2016
Q4 		$247K Buy
+26,400
New +$238K ﹤0.01% 801

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jacobs Levy Equity Management's AGTC Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2021, closing a stake of 348,560 shares — an estimated $1.05M sold.

Jacobs Levy Equity Management first reported a position in AGTC in Q4 2016 and held it in 18 quarters. The position peaked at $2.38M in Q1 2021. 55 funds tracked by Wall St. Rank hold AGTC as of Q4 2021.

  • Jacobs Levy Equity Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 348,560 Applied Genetic Technologies Corporation shares in Q4 2021, an estimated $1.05M.
  • Jacobs Levy Equity Management first reported a position in Applied Genetic Technologies Corporation in Q4 2016 and held it in 18 quarters.
  • Jacobs Levy Equity Management's Applied Genetic Technologies Corporation position peaked at $2.38M in Q1 2021.
  • 55 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.